Total Payments
$4,514
2022 Payments
$66.35
Companies
46
Transactions
308
Medicare Patients
9,339
Medicare Billing
$3.7M
Payment Breakdown by Category
Food & Beverage$4,315 (95.6%)
Education$199.41 (4.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,315 | 299 | 95.6% |
| Education | $199.41 | 9 | 4.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $553.30 | 42 | $0 (2021) |
| Janssen Biotech, Inc. | $529.96 | 35 | $0 (2020) |
| PFIZER INC. | $467.33 | 40 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $410.31 | 37 | $0 (2021) |
| Ipsen Biopharmaceuticals, Inc | $332.31 | 3 | $0 (2021) |
| Genentech USA, Inc. | $276.65 | 20 | $0 (2021) |
| Astellas Pharma US Inc | $213.07 | 12 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $212.48 | 12 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $180.51 | 14 | $0 (2021) |
| Pharmacyclics LLC, An AbbVie Company | $132.24 | 11 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $66.35 | 4 | SERVIER PHARMACEUTICALS LLC ($19.91) |
| 2021 | $624.49 | 40 | Novartis Pharmaceuticals Corporation ($109.10) |
| 2020 | $293.81 | 20 | E.R. Squibb & Sons, L.L.C. ($46.43) |
| 2019 | $981.67 | 77 | PFIZER INC. ($166.27) |
| 2018 | $1,328 | 102 | Novartis Pharmaceuticals Corporation ($223.40) |
| 2017 | $1,221 | 65 | Ipsen Biopharmaceuticals, Inc ($280.90) |
All Payment Transactions
308 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/24/2022 | PFIZER INC. | IBRANCE (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: ONCOLOGY | ||||||
| 09/01/2022 | GENZYME CORPORATION | ENJAYMO (Biological), CABLIVI | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Hematology | ||||||
| 05/19/2022 | SERVIER PHARMACEUTICALS LLC | TIBSOVO (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Oncology | ||||||
| 03/29/2022 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Oncology | ||||||
| 12/14/2021 | Pharmacosmos Therapeutics Inc. | Monoferric (Drug) | Education | In-kind items and services | $13.89 | General |
| Category: Hematology | ||||||
| 09/09/2021 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: ONCOLOGY | ||||||
| 08/25/2021 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), FEMARA, PIQRAY | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: ONCOLOGY | ||||||
| 06/25/2021 | Ipsen Biopharmaceuticals, Inc | SOMATULINE DEPOT (Drug), ONIVYDE | Food and Beverage | In-kind items and services | $28.32 | General |
| Category: Oncology/Endocrinology | ||||||
| 06/18/2021 | PUMA BIOTECHNOLOGY, INC. | NERLYNX (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: ONCOLOGY | ||||||
| 06/17/2021 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug), RYDAPT | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: ONCOLOGY | ||||||
| 06/09/2021 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $11.74 | General |
| Category: Oncology | ||||||
| 06/08/2021 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $12.14 | General |
| Category: ONCOLOGY | ||||||
| 06/01/2021 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), FEMARA, PIQRAY | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: ONCOLOGY | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 05/28/2021 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: ONCOLOGY | ||||||
| 05/27/2021 | Epizyme, Inc., | TAZVERIK (Drug) | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: ONCOLOGY | ||||||
| 05/25/2021 | Dova Pharmaceuticals | Doptelet (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: Hematology/Oncology | ||||||
| 05/20/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: ONCOLOGY | ||||||
| 05/19/2021 | Genentech USA, Inc. | GAZYVA (Biological), VENCLEXTA | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: BioOncology | ||||||
| 05/13/2021 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: ONCOLOGY | ||||||
| 05/13/2021 | GENZYME CORPORATION | JEVTANA (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: Oncology | ||||||
| 05/11/2021 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Oncology | ||||||
| 05/10/2021 | Secura Bio, Inc. | FARYDAK (Drug) | Education | In-kind items and services | $12.26 | General |
| Category: ORAL ONCOLOGIC | ||||||
| 05/06/2021 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug), TASIGNA | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: ONCOLOGY | ||||||
| 04/27/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug), COSELA | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 53 | 3,637 | 72,121 | $3.7M | $922,862 |
| 2020 | 83 | 5,702 | 210,286 | $10.7M | $2.8M |
Total Patients
9,339
Total Services
282,407
Medicare Billing
$3.7M
Procedure Codes
136
All Medicare Procedures & Services
136 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | Office | 2021 | 14 | 8,200 | $984,000 | $335,341 | 34.1% |
| J2505 | Injection, pegfilgrastim, 6 mg | Office | 2021 | 25 | 64 | $691,328 | $140,904 | 20.4% |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 2021 | 12 | 3,640 | $546,000 | $121,211 | 22.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 30 | 6,120 | $269,280 | $97,738 | 36.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 380 | 673 | $114,410 | $39,228 | 34.3% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 96 | 315 | $130,725 | $31,793 | 24.3% |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2021 | 19 | 3,550 | $124,250 | $23,810 | 19.2% |
| J1439 | Injection, ferric carboxymaltose, 1 mg | Office | 2021 | 17 | 24,750 | $66,825 | $22,116 | 33.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 123 | 152 | $38,152 | $13,362 | 35.0% |
| J0185 | Injection, aprepitant, 1 mg | Office | 2021 | 27 | 8,580 | $68,640 | $10,303 | 15.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 479 | 928 | $92,800 | $9,691 | 10.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 510 | 1,142 | $54,816 | $8,726 | 15.9% |
| 96367 | Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour | Office | 2021 | 68 | 315 | $36,540 | $6,811 | 18.6% |
| J2469 | Injection, palonosetron hcl, 25 mcg | Office | 2021 | 56 | 2,030 | $121,800 | $4,557 | 3.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 35 | 91 | $18,837 | $4,482 | 23.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 135 | 144 | $14,400 | $4,236 | 29.4% |
| 96417 | Infusion of different chemotherapy drug or substance into a vein up to 1 hour | Office | 2021 | 32 | 72 | $14,400 | $3,602 | 25.0% |
| 96375 | Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | Office | 2021 | 60 | 290 | $21,750 | $3,380 | 15.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 462 | 1,004 | $22,088 | $2,985 | 13.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 34 | 35 | $8,715 | $2,741 | 31.5% |
| 96401 | Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle | Office | 2021 | 19 | 51 | $8,415 | $2,687 | 31.9% |
| 82784 | Gammaglobulin (immune system protein) measurement | Office | 2021 | 51 | 287 | $18,655 | $2,669 | 14.3% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 75 | 255 | $14,790 | $2,559 | 17.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 23 | 23 | $8,786 | $2,515 | 28.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 22 | 24 | $7,824 | $2,496 | 31.9% |
About Dr. Bobby Wilkerson, M.D
Dr. Bobby Wilkerson, M.D is a Hematology & Oncology healthcare provider based in Jackson, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1245212844.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bobby Wilkerson, M.D has received a total of $4,514 in payments from pharmaceutical and medical device companies, with $66.35 received in 2022. These payments were reported across 308 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($4,315).
As a Medicare-enrolled provider, Wilkerson has provided services to 9,339 Medicare beneficiaries, totaling 282,407 services with total Medicare billing of $3.7M. Data is available for 2 years (2020–2021), covering 136 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Jackson, MS
- Active Since 11/18/2005
- Last Updated 05/24/2017
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1245212844
Products in Payments
- KEYTRUDA (Biological) $358.14
- IMBRUVICA (Drug) $328.06
- GILOTRIF (Drug) $212.48
- KISQALI (Drug) $177.21
- XTANDI (Drug) $173.08
- OPDIVO (Biological) $152.58
- IBRANCE (Drug) $123.59
- Imbruvica (Drug) $108.71
- Xtandi (Drug) $97.69
- DARZALEX (Biological) $96.59
- SUTENT (Drug) $96.39
- Erleada (Drug) $94.74
- ELITEK (Drug) $94.09
- TASIGNA (Drug) $81.36
- Kyprolis (Biological) $78.23
- PROMACTA (Drug) $77.53
- Nerlynx (Drug) $77.45
- Alecensa (Biological) $72.75
- MEKINIST (Drug) $69.35
- BOSULIF (Drug) $63.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Jackson
Guangzhi Qu, M.d, M.D
Hematology & Oncology — Payments: $55,663
Hematology & Oncology $55,663
John Henegan, M.d, M.D
Hematology & Oncology — Payments: $36,081
Hematology & Oncology $36,081
Gary Shi, Md, Phd, MD, PHD
Hematology & Oncology — Payments: $17,681
Hematology & Oncology $17,681
Barbara Craft, Md, MD
Hematology & Oncology — Payments: $17,539
Hematology & Oncology $17,539
Grace Shumaker, M.d, M.D
Hematology & Oncology — Payments: $5,378
Hematology & Oncology $5,378
Dr. Archie Wright, Do, DO
Hematology & Oncology — Payments: $4,360
Hematology & Oncology $4,360